P/E - Sol Gel Technologies Ltd (NASDAQ:SLGL) - Alpha Spread

Sol Gel Technologies Ltd
NASDAQ:SLGL

Watchlist Manager
Sol Gel Technologies Ltd Logo
Sol Gel Technologies Ltd
NASDAQ:SLGL
Watchlist
Price: 0.64 USD 3.23% Market Closed
Market Cap: 17.9m USD
Have any thoughts about
Sol Gel Technologies Ltd?
Write Note

P/E
Price to Earnings

-1.2
Current
-1.3
Median
21.6
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-1.2
=
Market Cap
17.8m USD
/
Net Income
-14.9m USD
All Countries
Close
Earnings Growth
IL
Sol Gel Technologies Ltd
NASDAQ:SLGL
Average P/E: 38.3
Negative Multiple: -1.2
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
119.7
425%
DK
Novo Nordisk A/S
CSE:NOVO B
45.3
90%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
10.6
-22%
US
Merck & Co Inc
NYSE:MRK
21.8
7 419%
CH
Roche Holding AG
SIX:ROG
18.4
30%
UK
A
AstraZeneca PLC
NASDAQ:AZN
38
175%
CH
Novartis AG
SIX:NOVN
14.1
20%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -65.1
712%

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-1.1
2-Years Forward
P/E
-1.3
3-Years Forward
P/E
-2.1

See Also

Discover More